You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroprotective

Showing 1 - 25 of 1,074
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Birth Asphyxia Trial (Magnesium sulfate)

Not yet recruiting
  • Birth Asphyxia
  • Magnesium sulfate
  • (no location specified)
Jan 22, 2023

Dexmedetomidine Neuroprotective Effect in Traumatic Brain Injury Trial in Tanta (Dexmedetomidine, salin infusion)

Recruiting
  • Dexmedetomidine Neuroprotective Effect in Traumatic Brain Injury
  • Tanta, Egypt
    Faculty of Medicine Tanta University
Aug 2, 2022

Patients After Traumatic Brain Injury

Completed
  • TBI (Traumatic Brain Injury)
  • Szczecin, Zachodniopomorskie, Poland
    Pomeranian Medical University
Mar 29, 2023

After Acute Ischemic Stroke

Completed
  • Acute Ischemic Stroke
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
    Jan 17, 2023

    Stroke, Ischemic, Intravascular Thrombosis, Mechanical Thrombectomy Trial in Shenyang (Intra-arterial administration of

    Recruiting
    • Stroke, Ischemic
    • +2 more
    • Intra-arterial administration of neuroprotective agents
    • Shenyang, China
      Department of Neurology, General Hospital of Northern Theater Co
    Aug 1, 2022

    Ischemic Stroke Trial (Xenon, Oxygen 30 %)

    Not yet recruiting
    • Ischemic Stroke
    • (no location specified)
    Sep 27, 2022

    Premature Birth, NEUROPROTECTION, MAGNESIUM SULPHATE Trial in Zagazig (Magnesium sulfate loading with maintenance dose,

    Not yet recruiting
    • Premature Birth
    • +4 more
    • Magnesium sulfate loading with maintenance dose
    • Magnesium sulfate loading dose only
    • Zagazig, Sharkia, Egypt
      Faculty of medicine, Zagazig University
    Dec 31, 2022

    Acute Ischemic Stroke (AIS) Trial in Columbus (Placebo, scp776 (1.9 mg/kg), scp776 (3.8 mg/kg))

    Recruiting
    • Acute Ischemic Stroke (AIS)
    • Placebo
    • +2 more
    • Columbus, Ohio
      The Ohio State University
    Jan 17, 2023

    Glaucoma Trial (Metformin, Placebo)

    Not yet recruiting
    • Glaucoma
    • (no location specified)
    Jun 17, 2022

    Retinal Detachment Trial (Lutein, Placebo)

    Completed
    • Retinal Detachment
    • Lutein
    • Placebo
    • (no location specified)
    Oct 31, 2022

    Ketamine-Induced Neurotoxicity Trial in Medan (ACTH4-10Pro8-Gly9-Pro10, Ketamine)

    Completed
    • Ketamine-Induced Neurotoxicity
    • Medan, Sumatera Utara, Indonesia
      Faculty of Medicine Universitas Sumatera Utara
    Dec 5, 2022

    Optic Neuropathy, Glaucoma Trial in Palo Alto (Hyperbaric Oxygen, Sham Hyperbaric Oxygen)

    Recruiting
    • Optic Neuropathy
    • Glaucoma
    • Hyperbaric Oxygen
    • Sham Hyperbaric Oxygen
    • Palo Alto, California
      Byers Eye Institute
    Nov 7, 2023

    Neuroprotection, Parkinson Disease, Intermittent Theta Burst Stimulation Trial in Shanghai (intermittent theta burst

    Not yet recruiting
    • Neuroprotection
    • +2 more
    • intermittent theta burst stimulation
    • sham iTBS
    • Shanghai, Shanghai, China
      Department of neurology, Ruijin Hospital, Shanghai Jiao Tong Uni
    Jun 30, 2022

    Cerebrovascular Disorders Trial in Kepala Batas (200mg of Palm vitamin E (tocotrienols) or )

    Completed
    • Cerebrovascular Disorders
    • 200mg of Palm vitamin E (tocotrienols) or placebo
    • Kepala Batas, Penang, Malaysia
      Kepala Batas Hospital
    May 18, 2022

    Ischemic Stroke, Neuroprotection Trial in Shenyang (Intra-arterial administration of neuroprotective agents)

    Active, not recruiting
    • Ischemic Stroke
    • Neuroprotection
    • Intra-arterial administration of neuroprotective agents
    • Shenyang, China
      Department of Neurology, General Hospital of Northern Theater Co
    Dec 31, 2021

    Innovative Non-Invasive Neuroprotective Technology in Cardiac

    Recruiting
    • Postoperative Cognitive Disorder
    • Glaucoma
    • Monitoring of cerebral autoregulation
    • Kaunas, Lithuania
      Milda Svagzdiene
    Apr 4, 2022

    Hypoxic Ischemic Encephalopathy Trial in Gainesville, Orlando (drug, other, behavioral)

    Recruiting
    • Hypoxic Ischemic Encephalopathy
    • Gainesville, Florida
    • +1 more
    May 23, 2022

    Premature Birth, Extreme Prematurity, Preterm Intraventricular Hemorrhage Trial in Moscow (Exosomes derived from mesenchymal

    Not yet recruiting
    • Premature Birth
    • +4 more
    • Exosomes derived from mesenchymal stromal cells (MSCs)
    • Moscow, Russian Federation
      Federal State Budget Institution Research Center for Obstetrics,
    Aug 3, 2022

    Anesthesia, Dexmedetomidine, Aging Trial in Santiago (Dexmedetomidine, Placebo)

    Recruiting
    • Anesthesia
    • +2 more
    • Santiago, Metropolitana, Chile
      Pontificia Universidad Catolica de Chile
    Mar 13, 2022

    Lower Extremity Amputee, Diabetic Peripheral Neuropathy Trial in Cleveland (Multi contact electrode implant)

    Recruiting
    • Lower Extremity Amputee
    • Diabetic Peripheral Neuropathy
    • Multi contact electrode implant
    • Cleveland, Ohio
      Louis Stokes VA Medical Center, Cleveland, OH
    Feb 3, 2022

    Vestibular Schwannoma Trial in Tuebingen (Remote ischemic preconditioning, Sham-control)

    Not yet recruiting
    • Vestibular Schwannoma
    • Remote ischemic preconditioning
    • Sham-control
    • Tuebingen, Germany
      University Hospital Tuebingen
    Sep 30, 2022

    Healthy Trial in Montréal (Episodic Specificity Induction, Associative Memory)

    Recruiting
    • Healthy
    • Episodic Specificity Induction
    • Associative Memory
    • Montréal, Quebec, Canada
      CRIUGM
    Oct 26, 2023

    Stroke, Endovascular Thrombectomy Trial in ShenYang (edaravone dexborneol)

    Recruiting
    • Stroke
    • Endovascular Thrombectomy
    • edaravone dexborneol
    • ShenYang, China
      General Hospital of Northern Theater Command
    Jan 7, 2022

    Cerebrovascular Stroke Trial in Madrid (Hemodialysis)

    Recruiting
    • Cerebrovascular Stroke
    • Hemodialysis
    • Madrid, Spain
      José Vivancos Mora, MD., PhD
    Dec 30, 2021

    Multiple Sclerosis, Relapsing-Remitting Trial in Münster (Alemtuzumab)

    Completed
    • Multiple Sclerosis, Relapsing-Remitting
    • Münster, Germany
      Universitätsklinikum Münster, Klinik für Allgemeine Neurologie
    Oct 25, 2021